title: Opportunistic infections and CD4 lymphocytopenia with interferon treatment in HIV-1 infected patients.
authors.forename: A
authors.initials: A
authors.lastname: Pesce
authors.forename: B
authors.initials: B
authors.lastname: Taillan
authors.forename: E
authors.initials: E
authors.lastname: Rosenthal
authors.forename: G
authors.initials: G
authors.lastname: Garnier
authors.forename: H
authors.initials: H
authors.lastname: Vinti
authors.forename: P
authors.initials: P
authors.lastname: Dujardin
authors.forename: J P
authors.initials: JP
authors.lastname: Cassuto
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications*; D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects*; D002908:Chronic Disease; D005260:Female; D006679:HIV Seropositivity / Q000150:complications*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D011994:Recombinant Proteins; D015819:Substance Abuse, Intravenous / Q000150:complications
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins